Now men & women in treatment for thinning hair can add astressin-B, a complex new peptide, to maximise hair-follicle benefits, because Spectral.F7 is the first solution to incorporate this protein fragment for human use in a topical booster agent. DS Laboratories Spectral.F7 Efficacy Booster Agent with Astressin augments primary therapies like Spectral.DNC-N® or minoxidil, & it can serve as an effective st&-alone treatment in early stages of thinning. In a recent clinical trial, the astressin-B peptide:
- Blocks receptors for corticotropin-releasing factor, involved in the stress response, in laboratory animals.
- Influences hair health when stress hormones are over-expressed.
- Performs well as a st&-alone therapy to treat stress-induced cases. Results from the trial mean that astressin-B offers a powerful new mechanism of action to treat atrophic follicles.